Search Term:  SEREBRUANY Serebruany V. Author Dipyridamole Decreases Protease-Activated Receptor and Annexin-V Binding on Platelets of Poststroke Patients with Aspirin Nonresponsiveness     Cerebrovascular Diseases 2006, Vol. 21, No. 1-2 Author Editors' Introductory Note     Heart Drug 2001, Vol. 1, No. 5 Author Editors' Introductory Note     Heart Drug 2002, Vol. 2, No. 1 Author Plasma Triglycerides as Predictors of Platelet Responsiveness to Aspirin in Patients after First Ischemic Stroke     Cerebrovascular Diseases 2008, Vol. 26, No. 3 Serebruany V.L. Author Aggrenox® (Extended-Release Dipyridamole and Low-Dose Aspirin in Combination): Protecting Platelets from Excessive Activation in Patients with Vascular Events     Heart Drug 2002, Vol. 2, No. 2 Author Antecedent Aspirin Therapy Inhibits Baseline Platelet Activity in Patients Presenting with Acute Myocardial Infarction     Cardiology 1998, Vol. 90, No. 1 Author Biomarkers and Exercise Training: A Possible Missing Link between Physical Activity and Mortality Benefit in Patients with Heart Failure     Heart Drug 2001, Vol. 1, No. 2 Author Bleeding Risks with Prasugrel in the TRITON Trial: Good News ... Bad News     Cardiology 2008, Vol. 111, No. 4 Author Clinical Utility of Available Methods for Determining Platelet Function     Cardiology 1999, Vol. 92, No. 4 Author Combination Antiplatelet Therapy with Aspirin and Clopidogrel: The Role of Antecedent and Concomitant Doses of Aspirin     Cardiology 2007, Vol. 107, No. 4 Author Combining Necrosis and Platelet Markers for Perfecting Myocardial Infarction Rule Out: How Close Are We?     Cardiology 2000, Vol. 93, No. 1-2 Author Depressed Plasma Platelet- Activating Factor Acetylhydrolasein Pat ients Presenting with Acute Myocardial Infarction     Cardiology 1998, Vol. 90, No. 2 Author Editors' Note     HeartDrug 2004, Vol. 4, No. 4 Author Editors' Note     HeartDrug 2003, Vol. 3, No. 1 Author Editors' Note     HeartDrug 2003, Vol. 3, No. 1 Author Failure of Platelet Parameters and Biomarkers to Correlate Platelet Function to Severity and Etiology of Heart Failure in Patients Enrolled in the EPCOT Trial     Pathophysiology of Haemostasis and Thrombosis 2002, Vol. 32, No. 1 Author Failure of Thrombin Generation Markers to Triage Patients Presenting with Chest Pain     Cardiology 1999, Vol. 92, No. 1 Author Intracoronary Magnesium and Diltiazem Affect to a Similar Extent Certain Hemostatic Factors during Acute Myocardial Infarction in Swine     Pharmacology 1996, Vol. 53, No. 4 Author Mac-1 Inhibitor Affects Certain Hemostatic Parameters during Myocardial Stunning in Swine     Pharmacology 1996, Vol. 53, No. 2 Author Platelet Function and Fibrinolytic Agents: Two Sides of a Coin?     Cardiology 2001, Vol. 95, No. 2 Author Platelets and Thrombolysis: Cooperation or Contrariety?     Heart Drug 2001, Vol. 1, No. 5 Author Prasugrel in the Poststroke Cohort of the TRITON Trial: The Clear and Present Danger     Cerebrovascular Diseases 2008, Vol. 26, No. 1 Author Pretreatment with an Inhibitor of Mac-1 Alters Regional and Systemic Platelet Function during Ischemia-Reperfusion in Swine     Pharmacology 1996, Vol. 53, No. 2 Author Selective Serotonin Reuptake Inhibitors: Future Treatment of Vascular Disease?     Heart Drug 2001, Vol. 1, No. 6 Author Soluble PECAM-1, but Not P-Selectin, Nor Osteonectin Identify Acute Myocardial Infarction in Patients Presenting with Chest Pain     Cardiology 1999, Vol. 91, No. 1 Author Soluble VCAM-1 and E-Selectin, but Not ICAM-1 Discriminate Endothelial Injury in Patients with Documented Coronary Artery Disease     Cardiology 2000, Vol. 93, No. 1-2 Author Statins Increase Risk of Hemorrhagic Stroke by Inhibition of the PAR-1 Receptor     Cerebrovascular Diseases 2007, Vol. 24, No. 5 Author Telmisartan and Stroke Reduction in the ONTARGET Trial: Benefit beyond Blood Pressure Lowering?     Cerebrovascular Diseases 2008, Vol. 26, No. 5 Author The FDA Prasugrel Review: Adjudication of Myocardial Infarction Controversy     Cardiology 2009, Vol. 114, No. 2 Author Welcome Address - from the Editors     Heart Drug 2001, Vol. 1, No. 1 Serebruany V.L., Towson, Md. Current  Editor Heart Drug    © 2009 S. Karger AG, Basel